Abstract
BackgroundPridopidine is a safe, well tolerated oral drug candidate in clinical development for HD and ALS. Pridopidine selectively activates the Sigma-1 receptor (S1R). S1R activation is neuroprotective, regulating vital cellular...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
